VF
TCON

Virtu Financial’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Virtu Financial’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,418
Closed -$8K – 2081
2023
Q2 		$8K Buy
+1,418
New +$25.9K ﹤0.01% 1375
2023
Q1 		– Sell
-2,264
Closed -$67K – 2283
2022
Q4 		$67K Buy
+2,264
New +$68.5K 0.01% 1031
2021
Q4 		– Sell
-747
Closed -$58K – 2290
2021
Q3 		$58K Buy
+747
New +$63.2K 0.01% 1249
2020
Q4 		– Sell
-3,059
Closed -$316K – 1885
2020
Q3 		$316K Buy
3,059
+1,126
+58% +$60.3K 0.05% 417
2020
Q2 		$76K Buy
+1,933
New +$76.5K 0.01% 941
2019
Q3 		– Sell
-167
Closed -$23K – 1929
2019
Q2 		$23K Buy
+167
New +$26.4K ﹤0.01% 1331
2019
Q1 		– Sell
-91
Closed -$11K – 1965
2018
Q4 		$11K Sell
91
-40
-31% -$10.9K ﹤0.01% 1434
2018
Q3 		$54K Buy
131
+38
+41% +$17.6K ﹤0.01% 1292
2018
Q2 		$50K Sell
93
-115
-55% -$61.2K ﹤0.01% 1752
2018
Q1 		$96K Buy
208
+153
+278% +$83.4K 0.01% 1589
2017
Q4 		$37K Sell
55
-63
-53% -$38K ﹤0.01% 2126
2017
Q3 		$75K Buy
+118
New +$61.5K ﹤0.01% 2144

Other funds holding TCON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Virtu Financial's TCON Position: Q3 2023 in Review

Virtu Financial sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2023, closing a stake of 1,418 shares — an estimated $8K sold.

Virtu Financial first reported a position in TCON in Q3 2017 and held it in 12 quarters. The position peaked at $316K in Q3 2020. 21 funds tracked by Wall St. Rank hold TCON as of Q3 2023.

  • Virtu Financial reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Virtu Financial sold 1,418 TRACON Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $8K.
  • Virtu Financial first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 12 quarters.
  • Virtu Financial's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $316K in Q3 2020.
  • 21 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.